ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 850,33
0,74%
DAX
18 869,36
0,78%
Brent Oil
82,565
0,02%
Bitcoin
65 084,15
5,75%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Forte Biosciences Inc (FBRX)

  7. Forte Biosciences Inc (FBRX) Actualités

FBRX

Forte Biosciences (FBRX)

Forte Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FBRX
DateHeureSourceTitreSymboleSociété
13/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBRXForte Biosciences Inc
13/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
16/02/202422h16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FBRXForte Biosciences Inc
14/02/202422h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FBRXForte Biosciences Inc
05/01/202423h27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FBRXForte Biosciences Inc
03/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
14/09/202322h00Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
14/09/202316h50Business WireISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual MeetingNASDAQ:FBRXForte Biosciences Inc
11/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBRXForte Biosciences Inc
08/09/202322h36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FBRXForte Biosciences Inc
06/09/202321h15Business WireConcerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s BoardroomNASDAQ:FBRXForte Biosciences Inc
01/09/202323h25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
29/08/202323h57Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FBRXForte Biosciences Inc
25/08/202316h10Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:FBRXForte Biosciences Inc
25/08/202314h00Business WireConcerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to StockholdersNASDAQ:FBRXForte Biosciences Inc
24/08/202312h17Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FBRXForte Biosciences Inc
23/08/202322h47Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:FBRXForte Biosciences Inc
17/08/202315h30Edgar (US Regulatory)Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwiseNASDAQ:FBRXForte Biosciences Inc
09/08/202318h23Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FBRXForte Biosciences Inc
02/08/202323h28Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:FBRXForte Biosciences Inc
26/06/202323h14Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:FBRXForte Biosciences Inc
26/06/202322h57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FBRXForte Biosciences Inc
10/04/202314h06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FBRXForte Biosciences Inc
31/03/202322h37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FBRXForte Biosciences Inc
31/03/202322h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FBRXForte Biosciences Inc
29/03/202317h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FBRXForte Biosciences Inc
23/03/202321h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FBRXForte Biosciences Inc
12/01/202322h04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FBRXForte Biosciences Inc
14/11/202222h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FBRXForte Biosciences Inc
17/08/202214h00Business WireCamac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital RaiseNASDAQ:FBRXForte Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:FBRX

Dernières Valeurs Consultées

NEO
ERDV
Evermore Retirement 2035...
TSXV
NCL.H
Nurcapital
LSE
0A8E
Xeris Biopharma
AQSE
BIOM.GB
Biome Technologies
BIT
P1R783
BNP Paribas Issuance
LSE
UC84
Ubsetf Cbus
BIT
F16006
Vontobel Financial Produ...
NYSE
PSW
ASX
YTMF16
Equity Trustees
BIT
UC467N
Unicredit Bank
EU
FRSOP
Euronext France Social
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés